Cargando…
The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173782/ https://www.ncbi.nlm.nih.gov/pubmed/30291223 http://dx.doi.org/10.1038/s41408-018-0126-z |
| _version_ | 1783361182058414080 |
|---|---|
| author | Sekeres, Mikkael A. Swern, Arlene S. Giagounidis, Aristoteles List, Alan F. Selleslag, Dominik Mittelman, Moshe Schlegelberger, Brigitte Göhring, Gudrun Li, Jack Shiansong Sugrue, Mary M. Fenaux, Pierre |
| author_facet | Sekeres, Mikkael A. Swern, Arlene S. Giagounidis, Aristoteles List, Alan F. Selleslag, Dominik Mittelman, Moshe Schlegelberger, Brigitte Göhring, Gudrun Li, Jack Shiansong Sugrue, Mary M. Fenaux, Pierre |
| author_sort | Sekeres, Mikkael A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6173782 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61737822018-10-09 The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q) Sekeres, Mikkael A. Swern, Arlene S. Giagounidis, Aristoteles List, Alan F. Selleslag, Dominik Mittelman, Moshe Schlegelberger, Brigitte Göhring, Gudrun Li, Jack Shiansong Sugrue, Mary M. Fenaux, Pierre Blood Cancer J Correspondence Nature Publishing Group UK 2018-09-21 /pmc/articles/PMC6173782/ /pubmed/30291223 http://dx.doi.org/10.1038/s41408-018-0126-z Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Sekeres, Mikkael A. Swern, Arlene S. Giagounidis, Aristoteles List, Alan F. Selleslag, Dominik Mittelman, Moshe Schlegelberger, Brigitte Göhring, Gudrun Li, Jack Shiansong Sugrue, Mary M. Fenaux, Pierre The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q) |
| title | The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q) |
| title_full | The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q) |
| title_fullStr | The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q) |
| title_full_unstemmed | The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q) |
| title_short | The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q) |
| title_sort | impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q) |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173782/ https://www.ncbi.nlm.nih.gov/pubmed/30291223 http://dx.doi.org/10.1038/s41408-018-0126-z |
| work_keys_str_mv | AT sekeresmikkaela theimpactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT swernarlenes theimpactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT giagounidisaristoteles theimpactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT listalanf theimpactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT selleslagdominik theimpactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT mittelmanmoshe theimpactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT schlegelbergerbrigitte theimpactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT gohringgudrun theimpactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT lijackshiansong theimpactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT sugruemarym theimpactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT fenauxpierre theimpactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT sekeresmikkaela impactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT swernarlenes impactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT giagounidisaristoteles impactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT listalanf impactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT selleslagdominik impactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT mittelmanmoshe impactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT schlegelbergerbrigitte impactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT gohringgudrun impactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT lijackshiansong impactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT sugruemarym impactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q AT fenauxpierre impactoflenalidomideexposureonresponseandoutcomesinpatientswithlowerriskmyelodysplasticsyndromesanddel5q |